Skip to main content

Table 2 Trial descriptive and recruitment information by year started

From: Update on the clinical trial landscape: analysis of ClinicalTrials.gov registration data, 2000–2020

A: Counts (n) by year started

Year started

Trials started

Sponsor

Has DSMC

Protocol included

Sex

Age

N

Industry

NIH/US Gov

Other

Yes

Yes

Men only

Women only

All

Adults only

Children only

Adults and children

2000

1873

456

323

1094

373

6

87

224

1552

248

113

1512

2001

2399

746

359

1294

432

3

125

286

1974

363

129

1907

2002

3492

1336

427

1729

683

11

173

376

2935

558

217

2717

2003

4765

1773

420

2572

1040

15

254

490

4012

817

292

3656

2004

6314

2380

549

3385

1433

36

322

651

5331

1016

380

4918

2005

7728

2832

499

4397

1973

55

388

707

6624

1259

489

5980

2006

9297

3558

523

5216

2748

67

474

863

7950

1630

581

7086

2007

10,412

3940

415

6057

3714

62

531

992

8883

1911

622

7879

2008

11,874

4364

399

7111

4239

105

652

1143

10,066

2244

689

8941

2009

12,825

4379

402

8044

4794

177

729

1156

10,928

2473

787

9565

2010

13,402

4289

459

8654

5093

211

732

1221

11,441

2619

814

9969

2011

14,175

4420

411

9344

5391

334

831

1304

12,024

2877

919

10,379

2012

14,995

4271

344

10,380

5914

554

847

1454

12,683

3069

973

10,953

2013

15,829

4223

352

11,254

6141

940

909

1438

13,471

3279

998

11,552

2014

17,508

4581

350

12,577

6545

1391

985

1684

14,822

3682

1110

12,716

2015

18,807

4621

378

13,808

6844

2268

967

2003

15,814

3890

1157

13,760

2016

20,168

4586

370

15,212

7096

3013

994

2107

17,044

4097

1317

14,754

2017

20,917

4529

354

16,034

7263

3310

1006

2163

17,739

4248

1338

15,331

2018

22,285

4875

374

17,036

7170

2814

983

2243

19,042

4416

1429

16,440

2019

22,847

4832

377

17,638

7370

1699

995

2241

19,602

4441

1378

17,028

2020

22,131

4918

270

16,943

7565

835

859

1958

19,306

4038

1159

16,934

Total

274,043

75,909

8355

189,779

93,821

17,906

13,843

26,704

233,243

53,175

16,891

203,977

B: Percent (%) by year

 

Sponsor

Has DSMC

Protocol included

Eligibility: sexa, b

Eligibility: age (%)

Year started

Industry

NIH/US Gov

Other

Yes

(%)

Yes

(%)

Men only (%)

Women only (%)

All (%)

Adults only (%)

Children only (%)

Adults and children

2000

24.3

17.2

58.4

19.9

0.3

4.6

12.0

82.9

13.2

6.0

80.7

2001

31.1

15.0

53.9

18

0.1

5.2

11.9

82.3

15.1

5.4

79.5

2002

38.3

12.2

49.5

19.6

0.3

5.0

10.8

84.0

16.0

6.2

77.8

2003

37.2

8.8

54.0

21.8

0.3

5.3

10.3

84.2

17.1

6.1

76.7

2004

37.7

8.7

53.6

22.7

0.6

5.1

10.3

84.4

16.1

6.0

77.9

2005

36.6

6.5

56.9

25.5

0.7

5.0

9.1

85.7

16.3

6.3

77.4

2006

38.3

5.6

56.1

29.6

0.7

5.1

9.3

85.5

17.5

6.2

76.2

2007

37.8

4.0

58.2

35.7

0.6

5.1

9.5

85.3

18.4

6.0

75.7

2008

36.8

3.4

59.9

35.7

0.9

5.5

9.6

84.8

18.9

5.8

75.3

2009

34.1

3.1

62.7

37.4

1.4

5.7

9.0

85.2

19.3

6.1

74.6

2010

32.0

3.4

64.6

38.0

1.6

5.5

9.1

85.4

19.5

6.1

74.4

2011

31.2

2.9

65.9

38.0

2.4

5.9

9.2

84.8

20.3

6.5

73.2

2012

28.5

2.3

69.2

39.4

3.7

5.6

9.7

84.6

20.5

6.5

73.0

2013

26.7

2.2

71.1

38.8

5.9

5.7

9.1

85.1

20.7

6.3

73.0

2014

26.2

2.0

71.8

37.4

7.9

5.6

9.6

84.7

21.0

6.3

72.6

2015

24.6

2.0

73.4

36.4

12.1

5.1

10.7

84.1

20.7

6.2

73.2

2016

22.7

1.8

75.4

35.2

14.9

4.9

10.4

84.5

20.3

6.5

73.2

2017

21.7

1.7

76.7

34.7

15.8

4.8

10.3

84.8

20.3

6.4

73.3

2018

21.9

1.7

76.4

32.2

12.6

4.4

10.1

85.4

19.8

6.4

73.8

2019

21.1

1.7

77.2

32.3

7.4

4.4

9.8

85.8

19.4

6.0

74.5

2020

22.2

1.2

76.6

34.2

3.8

3.9

8.8

87.2

18.2

5.2

76.5

Average

30.0

5.1

64.8

31.5

4.5

5.1

9.9

84.8

18.5

6.1

75.4

  1. aMay not add up to 100%, due to missing data (see Table 4)
  2. bAs defined in ClinicalTrials.gov, sex based on biological distinctions and distinct from gender-based eligibility